NfL Levels May Presage MS Disability
Spikes in neurofilament light chain levels occur about 1 year before clinical signs of disease worsening in multiple sclerosis, new research suggests.
Stay updated with breaking news from Iological Marker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Spikes in neurofilament light chain levels occur about 1 year before clinical signs of disease worsening in multiple sclerosis, new research suggests.
After just 6 weeks of antidepressant therapy, regardless of modality, brain connectivity is increased in patients with major depressive disorder in line with symptom improvement, new research suggests.
A measure of bicarbonate in urine was associated with both disease severity and response to treatment in a new study.
The researchers' goal is to identify molecular markers and clinical data that identify patients who are likely to respond to treatment and those who are likely to be nonresponders.
The central vein sign is an emerging neuroimaging biomarker for multiple sclerosis that may reduce the need for lumbar puncture to detect oligoclonal bands in CSF, a pilot study shows.